Home > Income Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Consolidated Net Profit

    Back to Income Statement
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Consolidated Net Profit ₹297 Cr₹942 Cr₹970 Cr₹776 Cr₹925 Cr

What is the latest Consolidated Net Profit of GLENMARK PHARMACEUTICALS ?

The latest Consolidated Net Profit ratio of GLENMARK PHARMACEUTICALS is ₹297 Cr based on Mar2024 Consolidated results.
Year Consolidated Net Profit
Mar2024₹297 Cr
Mar2023₹942 Cr
Mar2022₹970 Cr
Mar2021₹776 Cr
Mar2020₹925 Cr

How is Consolidated Net Profit of GLENMARK PHARMACEUTICALS Trending?

Years Consolidated Net Profit % Change
Mar2024 ₹297 Cr
-68.44
Mar2023 ₹942 Cr
-2.92
Mar2022 ₹970 Cr
25.01
Mar2021 ₹776 Cr
-16.11
Mar2020 ₹925 Cr -

Compare Consolidated Net Profit of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹40,810.4 Cr 3.7% 5% 40.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,400.0 Cr -0.3% 3.1% 13.4% Stock Analytics
DIVIS LABORATORIES ₹164,844.0 Cr 3.5% 11% 63.5% Stock Analytics
CIPLA ₹121,328.0 Cr 1.6% 2.7% 11.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,521.0 Cr 4.1% 4.4% 24.7% Stock Analytics
DR REDDYS LABORATORIES ₹103,043.0 Cr 6.8% 11.3% 3.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

3.7%

5%

40.9%

SENSEX

2.7%

11.8%

14%


You may also like the below Video Courses